Sec Form 3 Filing - Mahajan Manmohan @ Walgreens Boots Alliance, Inc. - 2021-07-14

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 3
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Mahajan Manmohan
2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [ WBA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SVP, Global Controller and CAO
(Last) (First) (Middle)
C/O WALGREENS BOOTS ALLIANCE, 108 WILMOT ROAD
3. Date of Earliest Transaction (MM/DD/YY)
07/14/2021
(Street)
DEERFIELD, IL60015
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3,425 ( 1 ) ( 2 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $ 82.46 11/01/2019 11/01/2026 Common Stock 7,335 D
Employee Stock Option (Right to Buy) $ 67.01 ( 3 ) 11/01/2027 Common Stock 8,579 D
Employee Stock Option (Right to Buy) $ 79.9 ( 4 ) 11/01/2028 Common Stock 6,789 D
Employee Stock Option (Right to Buy) $ 57.38 ( 5 ) 11/01/2029 Common Stock 9,191 D
Employee Stock Option (Right to Buy) $ 34.04 ( 6 ) 11/01/2030 Common Stock 10,829 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mahajan Manmohan
C/O WALGREENS BOOTS ALLIANCE
108 WILMOT ROAD
DEERFIELD, IL60015
SVP, Global Controller and CAO
Signatures
/s/ Manmohan Mahajan by Cherita Thomas, Attorney-in-Fact 07/26/2021
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Reflects shares underlying restricted stock units ("RSUs") granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan"), and shares underlying restricted stock units issued in lieu of dividends (through July 15, 2021) on outstanding restricted stock units. (continued in footnote 2)
( 2 )(continued from footnote 1) RSUs were granted and vest as follows (a) 1,118 RSUs granted on November 1, 2019 that vest with respect to 558 shares on November 1, 2021 and with respect to 560 shares on November 1, 2022; and (b) 2,160 RSUs granted on November 1, 2020 that vest with respect to 719 shares on November 1, 2021, with respect to 719 shares on November 1, 2022 and with respect to 722 shares on November 1, 2023.
( 3 )The option vests with respect to 2,856 shares on November 1, 2018, with respect to 2,857 shares on November 1, 2019, and with respect to 2,866 shares on November 1, 2020, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
( 4 )The option vests with respect to 2,260 shares on November 1, 2019, with respect to 2,261 shares on November 1, 2020, and with respect to 2,268 shares on November 1, 2021, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
( 5 )The option vests with respect to 3,060 shares on November 1, 2020, with respect to 3,061 shares on November 1, 2021, and with respect to 3,070 shares on November 1, 2022, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.
( 6 )The option vests with respect to 3,606 shares on November 1, 2021, with respect to 3,606 shares on November 1, 2022, and with respect to 3,617 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.